Prolife Indust. (PROLIFE)

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• High promoter holding of 73.74% aligns owner interests with minority shareholders
• Modest P/E of 10.22 offers a low headline valuation
• Positive ROCE of 14.35% suggests decent capital efficiency at the operating level
• Sales growth of 7.76% shows some demand resilience

Concerns

• Profit growth declined sharply by 60.27%, indicating severe margin compression
• Latest quarter net profit of ₹1 crore on ₹29 crore sales implies a thin margin
• Piotroski F-Score of 4/9 points to weak financial and operational health
• Missing balance sheet data like book value and debt/equity makes a full Graham-style safety analysis impossible

AI Analysis

At ₹72.25, Prolife Indust. is a tiny ₹25 crore player in dyes and pigments. Graham would remind me that a small market cap means limited liquidity and greater fragility. The first red flag is earnings quality: profit growth has collapsed 60.27% despite sales rising 7.76%. That tells me margins are under severe pressure. Latest quarter sales of ₹29 crore produced only ₹1 crore net profit, a roughly 3.4% margin. The P/E of 10.22 flatters the stock because the 'E' is depressed; I don't pay a multiple to a cyclical trough unless I understand the cycle. Piotroski F-Score of 4/9 confirms weak financial health and poor operating efficiency. ROCE of 14.35% is respectable, but with no debt/equity or book value disclosed, I cannot judge leverage or downside protection. Promoter holding at 73.74% is a positive—it aligns owners with minority holders, though it also reduces floating stock and can exaggerate price swings. The 52-week range of ₹56.05 to ₹142.50 shows this is a volatile, cyclical business, not a steady compounder. I need a margin of safety. At current price, the market is pricing in a bounce if the cycle turns, and PEG of 1.32 is not compelling given negative profit momentum. I would not call this a wonderful business at a fair price; it is more likely a cyclical at perhaps an interesting price. I would wait for evidence of margin stabilization, a better F-score, and a clearer balance sheet before committing capital. In Mr. Market's terms, this is in the 'too hard' pile for now.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer